Remarkably, we found a differential increase between sEOAD and ADAD patients, namely, gene-driven AD increased TREM2 expression levels by almost twice as much as sporadic AD, a similar fold difference as in the transgenic 5XFAD mouse model compared to aged SAMP8 mice. Here, TREM2 is linked to Alzheimer disease.